Hernia Mesh Devices Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The hernia mesh devices market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to clinical acceptance, aging population, hospital infrastructure, rising respiratory disorders, clinical studies and guidelines.

The hernia mesh devices market size is expected to see steady growth in the next few years. It will grow to $5.47 billion in 2029 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to homecare settings, prevalence of chronic diseases, global health crises preparedness, awareness and education, shift towards non-invasive therapies. Major trends in the forecast period include development of portable and lightweight hfnc devices, focus on patient-centric design and comfort features, introduction of wireless monitoring and connectivity, application in non-invasive ventilation (niv) strategies, emphasis on evidence-based clinical guidelines, integration of advanced flow control algorithms.

The hernia mesh devices market is anticipated to experience significant growth due to the rising prevalence of hernia repairs. Hernia repair is a surgical intervention aimed at strengthening the weakened abdominal wall and returning the hernia bulge to its proper position. Hernia mesh devices play a crucial role in these procedures, reducing the risk of recurrence and improving patient outcomes. A report from the National Library of Medicine in August 2023 highlighted that approximately 800,000 repairs are conducted annually for inguinal hernias in the United States alone, underscoring the increasing frequency of hernia repairs and its impact on the market.

The expansion of the hernia mesh devices market is also expected to be fueled by the growing population of individuals with obesity. Obesity, characterized by abnormal or excessive fat accumulation, poses health risks and necessitates effective solutions. Hernia mesh devices are frequently employed in obese populations to enhance support for weakened tissue and reduce recurrence rates compared to traditional suture repair. As of March 2022, the World Health Organization reported that over 1 billion people worldwide are currently obese, with 650 million being adults, 340 million adolescents, and 39 million children. The projection that around 167 million people will face health challenges related to overweight or obesity by 2025 further emphasizes the role of the growing obese population in propelling the hernia mesh devices market.

Leading companies in the hernia mesh devices market are focusing on the development of innovative products, such as the GORE SYNECOR Intraperitoneal Biomaterial, to improve patient outcomes by minimizing complications. The GORE SYNECOR Intraperitoneal Biomaterial is specifically designed for the treatment of ventral or incisional hernias and may require the incorporation of a non-absorbable bridging or strengthening material. For example, in April 2022, Ariste Medical, a U.S.-based pre-commercial drug and device firm, received 510(k) clearance from the FDA to market its groundbreaking drug-embedded synthetic hernia mesh in the United States. This novel product aims to lower the risk of microbial colonization during hernia surgeries. The development of this advanced mesh involved substantial investments in research and adherence to strict regulatory standards. By incorporating antibiotics into the mesh, Ariste Medical seeks to enhance patient outcomes and decrease infection rates. This launch underscores the ongoing efforts to improve the effectiveness and reliability of hernia repair solutions.

In May 2024, Kohlberg Kravis Roberts & Co. Inc. (KKR), a U.S.-based investment firm, acquired Healthium MedTech for an undisclosed amount. This acquisition enables KKR to leverage its extensive network and healthcare expertise to enhance Healthium's product offerings and broaden its global reach. The strategic initiative aims to facilitate the development of advanced hernia repair devices, ensuring they adhere to rigorous safety and efficacy standards through substantial investment in research and development. Healthium, an India-based medical devices company, is recognized for its diverse range of surgical products, including hernia mesh devices, which play a vital role in hernia repair surgeries.

Major companies operating in the hernia mesh devices market report are Johnson & Johnson Services Inc., 3M Company, Medtronic PLC, Stryker Corporation, GE HealthCare Technologies Inc., Betatech Medical, Ethicon Inc., B. Braun Melsungen AG, W.L. Gore & Associates Inc., Cook Medical Inc., Samyang Corporation, Integra Life Sciences Pvt. Ltd., LifeCell Corporation, Meril Life Sciences Pvt Ltd., Sinolinks Medical Innovation Inc Inc., Aspide Medical S.A.S., C.R. Bard Inc., Bard Inc., Deep Blue Medical Inc., Changzhou Medical Equipment General Factory Co. Ltd., Katsan Katgut Sanayi ve Tic. A.S., BioCer Entwicklungs-GmbH, Dipromed S.r.l., Herniamesh S.r.l., Novus Scientific AB, Gem S.r.l., Atrium Health, Primequal SA.

North America was the largest region in the hernia mesh devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hernia mesh devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hernia mesh devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hernia mesh devices market consists of sales of synthetic mesh, composite mesh, absorbable mesh, mesh with coating, 3D meshes, and mesh kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

A hernia mesh device is a medical implant or surgical mesh employed in the treatment of hernias. A hernia arises when an organ or fatty tissue protrudes through a weakened spot or opening in the surrounding muscle or connective tissue, typically occurring in the abdominal wall. Hernia mesh devices are utilized in hernia repair surgeries to provide support to damaged tissue and reinforce the abdominal wall, thereby reducing the risk of recurrence.

The primary categories of hernia mesh devices include biologic mesh and synthetic mesh. Biologic mesh, also referred to as bioprosthetic mesh or biological mesh, is a variety of surgical mesh utilized in hernia repair and other soft tissue surgeries. These meshes find application in various procedures, including open surgeries, laparoscopic surgeries, and robotic surgeries for incisional hernia, umbilical hernia, inguinal hernia, femoral hernia, and other types, performed by hospitals, clinics, ambulatory surgical centers, and other end users.

The hernia mesh devices market research report is one of a series of new reports that provides hernia mesh devices market statistics, including hernia mesh devices industry global market size, regional shares, competitors with a hernia mesh devices market share, detailed hernia mesh devices market segments, market trends and opportunities, and any further data you may need to thrive in the hernia mesh devices industry. This hernia mesh devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.